Transcatheter Aortic Valve Replacement: 2015 in Review

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Medical Technology

Background:

• Severe symptomatic aortic stenosis (AS) poses significant risks for surgical valve replacement.
• Transcatheter aortic valve replacement (TAVR) offers an alternative for high-risk and extreme-risk patients.
• Continuous innovation is crucial in TAVR development.

Purpose of the Study:

• To summarize significant advancements in TAVR technology and clinical application.
• To provide an overview of TAVR progress reported in 2015.
• To highlight key developments relevant to interventional cardiology.

Main Methods:

• Review of major TAVR publications and reports from 2015.
• Synthesis of key findings and technological improvements.
• Analysis of clinical outcomes and procedural refinements.

Main Results:

• Significant progress in TAVR device technology and delivery systems.
• Expansion of TAVR indications and improved patient selection criteria.
• Emerging data on long-term TAVR outcomes and safety profiles.

Conclusions:

• TAVR continues to evolve as a vital treatment for severe AS.
• 2015 saw notable advancements enhancing TAVR safety and efficacy.
• TAVR is increasingly becoming a standard of care for eligible patients.